Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Immunogenic cell death (ICD) is a unique mode of cell death that could trigger tumour-specific immune response. Metal-based drugs which have emerged as promising agents within the lexicon of possible ICD inducers will be the topic of this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Platinum-based drugs have demonstrated potential to induce an anti-cancer immune response by promoting the recruitment and activation of immune cells [95, 96], thereby enhancing the efficacy of immunotherapies.”
From Advances in platinum-based cancer therapy: overcoming platinum resistance through rational combinatorial strategies (2025) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sabbatini, M., Zanellato, I., Ravera, M., Gabano, E., Perin, E., Rangone, B., & Osella, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01860 · Cited by 63
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
Immunological aspects of cancer chemotherapy
Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Monro, S., Colón, K. L., Yin, H., Roque, J., Konda, P., Gujar, S., Thummel, R. P., Lilge, L., Cameron, C. G., & McFarland, S. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00211 · Cited by 1,461
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377
Cancer despite immunosurveillance: immunoselection and immunosubversion
Zitvogel, L., Tesniere, A., & Kroemer, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1936 · Cited by 1,324
Immunogenic death of colon cancer cells treated with oxaliplatin
Tesniere, A., Schlemmer, F., Boige, V, Kepp, O., Martins, I., Ghiringhelli, F., Aymeric, L., Michaud, M., Apetoh, L., Barault, L., et al. (2010) · Oncogene · doi:10.1038/onc.2009.356 · Cited by 1,173
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Galluzzi, L., Vitale, I., Warren, S., Adjemian, S., Agostinis, P., Martinez, A. B., Chan, T. A., Coukos, G., Demaria, S., Deutsch, E., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000337 · Cited by 1,119
Zitvogel, L., Galluzzi, L., Smyth, M. J., & Kroemer, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.014 · Cited by 870
Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death
Panaretakis, T., Kepp, O., Brockmeier, U., Tesniere, A., Bjorklund, A., Chapman, D. C., Durchschlag, M., Joza, N., Pierron, G., van Endert, P., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.1 · Cited by 848
Consensus guidelines for the detection of immunogenic cell death
Kepp, O., Senovilla, L., Vitale, I., Vacchelli, E., Adjemian, S., Agostinis, P., Apetoh, L., Aranda, F., Barnaba, V., Bloy, N., et al. (2014) · OncoImmunology · doi:10.4161/21624011.2014.955691 · Cited by 832
Lebwohl, D., & Canetta, R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00224-x · Cited by 754
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
Golden, E. B., Frances, D., Pellicciotta, I., Demaria, S., Helen Barcellos-Hoff, M., & Formenti, S. C. (2014) · OncoImmunology · doi:10.4161/onci.28518 · Cited by 624
Molecular mechanisms of ATP secretion during immunogenic cell death
Martins, I., Wang, Y., Michaud, M., Ma, Y., Sukkurwala, A. Q., Shen, S., Kepp, O., Métivier, D., Galluzzi, L., Perfettini, J.-L., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.75 · Cited by 563
Zhou, F., Feng, B., Yu, H., Wang, D., Wang, T., Ma, Y., Wang, S., & Li, Y. (2019) · Advanced Materials · doi:10.1002/adma.201805888 · Cited by 507
Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
Menger, L., Vacchelli, E., Adjemian, S., Martins, I., Ma, Y., Shen, S., Yamazaki, T., Sukkurwala, A. Q., Michaud, M., Mignot, G., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003807 · Cited by 423
Martins, I., Kepp, O., Schlemmer, F., Adjemian, S., Tailler, M., Shen, S., Michaud, M., Menger, L., Gdoura, A., Tajeddine, N., et al. (2011) · Oncogene · doi:10.1038/onc.2010.500 · Cited by 414
Fucikova, J., Spisek, R., Kroemer, G., & Galluzzi, L. (2021) · Cell Research · doi:10.1038/s41422-020-0383-9 · Cited by 400
Zheng, P., Ding, B., Jiang, Z., Xu, W., Li, G., Ding, J., & Chen, X. (2021) · Nano Letters · doi:10.1021/acs.nanolett.0c04778 · Cited by 359
Ding, B., Zheng, P., Jiang, F., Zhao, Y., Wang, M., Chang, M., Ma, P., & Lin, J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202005111 · Cited by 341
Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy
Wu, J., & Waxman, D. J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.050 · Cited by 320
Wang, L., Guan, R., Xie, L., Liao, X., Xiong, K., Rees, T. W., Chen, Y., Ji, L., & Chao, H. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202013987 · Cited by 289
Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
Garg, A. D., More, S., Rufo, N., Mece, O., Sassano, M. L., Agostinis, P., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1386829 · Cited by 276
Duan, X., Chan, C., Han, W., Guo, N., Weichselbaum, R. R., & Lin, W. (2019) · Nature Communications · doi:10.1038/s41467-019-09221-x · Cited by 256
Inducers of immunogenic cancer cell death
Dudek, A. M., Garg, A. D., Krysko, D. V., De Ruysscher, D., & Agostinis, P. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.01.005 · Cited by 250
Self‐Amplified Drug Delivery with Light‐Inducible Nanocargoes to Enhance Cancer Immunotherapy
Feng, B., Hou, B., Xu, Z., Saeed, M., Yu, H., & Li, Y. (2019) · Advanced Materials · doi:10.1002/adma.201902960 · Cited by 245
Garg, A. D., Dudek-Peric, A. M., Romano, E., & Agostinis, P. (2015) · The International Journal of Developmental Biology · doi:10.1387/ijdb.150061pa · Cited by 240
Deng, Z., Wang, N., Liu, Y., Xu, Z., Wang, Z., Lau, T.-C., & Zhu, G. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c00221 · Cited by 239
Crosstalk between ER stress and immunogenic cell death
Kepp, O., Menger, L., Vacchelli, E., Locher, C., Adjemian, S., Yamazaki, T., Martins, I., Sukkurwala, A. Q., Michaud, M., Senovilla, L., et al. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.05.001 · Cited by 233
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
Vanmeerbeek, I., Sprooten, J., De Ruysscher, D., Tejpar, S., Vandenberghe, P., Fucikova, J., Spisek, R., Zitvogel, L., Kroemer, G., Galluzzi, L., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2019.1703449 · Cited by 227
Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
Gao, J., Wang, W.-Q., Pei, Q., Lord, M. S., & Yu, H.-J. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0400-z · Cited by 203
Endoplasmic reticulum stress: an arising target for metal-based anticancer agents
King, A. P., & Wilson, J. J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00259c · Cited by 189
Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes
Wong, D. Y. Q., Ong, W. W. F., & Ang, W. H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500934 · Cited by 185
Anticancer metal drugs and immunogenic cell death
Terenzi, A., Pirker, C., Keppler, B. K., & Berger, W. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.06.021 · Cited by 151
Wernitznig, D., Kiakos, K., Favero, G. D., Harrer, N. E., Machat, H., Oßwald, A., Jakupec, M. A., Wernitznig, A., Sommergruber, W., & Keppler, B. K. (2019) · Metallomics · doi:10.1039/c9mt00051h · Cited by 148
Tham, M. J. R., Babak, M. V., & Ang, W. H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202008604 · Cited by 142
Rationally Designed Redox-Active Au(I) N-Heterocyclic Carbene: An Immunogenic Cell Death Inducer
Sen, S., Hufnagel, S., Maier, E. Y., Aguilar, I., Selvakumar, J., DeVore, J. E., Lynch, V. M., Arumugam, K., Cui, Z., Sessler, J. L., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c09753 · Cited by 126
Self-citationYamazaki, T., Buqué, A., Ames, T. D., & Galluzzi, L. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1721810 · Cited by 121
Kaur, P., Johnson, A., Northcote‐Smith, J., Lü, C., & Suntharalingam, K. (2020) · ChemBioChem · doi:10.1002/cbic.202000553 · Cited by 108
Luo, Y., Chihara, Y., Fujimoto, K., Sasahira, T., Kuwada, M., Fujiwara, R., Fujii, K., Ohmori, H., & Kuniyasu, H. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.016 · Cited by 105
Wang, Y., Ding, Y., Yao, D., Dong, H., Ji, C., Wu, J., Hu, Y., & Yuan, A. (2021) · Small · doi:10.1002/smll.202006231 · Cited by 100
Pan, Z., Tan, C., Rao, L., Zhang, H., Zheng, Y., Liang, H., Ji, L., & Mao, Z. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202008624 · Cited by 87
Sun, F., Cui, L., Li, T., Chen, S., Jun-mei, S., & Li, D. (2019) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2019.1655050 · Cited by 83
Platinum Derivatives Effects on Anticancer Immune Response
Rébé, C., Demontoux, L., Pilot, T., & Ghiringhelli, F. (2019) · Biomolecules · doi:10.3390/biom10010013 · Cited by 79
Loenhout, J. V., Boullosa, L. F., Quatannens, D., Waele, J. D., Merlin, C., Lambrechts, H. A. J., Lau, H. W., Hermans, C., Lin, A. G., Lardon, F., et al. (2021) · Cells · doi:10.3390/cells10112936 · Cited by 77
Zhu, Q., Sun, F. Z., Li, T., Zhou, M., Ye, J., Ji, A., Wang, H., Ding, C., Chen, H., Xu, Z., et al. (2021) · Small · doi:10.1002/smll.202007882 · Cited by 73
Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
Jungwirth, U., Xanthos, D. N., Gojo, J., Bytzek, A. K., Körner, W., Heffeter, P., Abramkin, S. A., Jakupec, M. A., Hartinger, C. G., Windberger, U. B., et al. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.077321 · Cited by 72
Huang, K.-B., Wang, F.-Y., Feng, H.-W., Luo, H., Long, Y., Zou, T., Chan, A. S. C., Liu, R., Zou, H., Chen, Z., et al. (2019) · Chemical Communications · doi:10.1039/c9cc06563f · Cited by 69
Induction of immunogenic cell death in cancer cells by a photoactivated platinum( iv ) prodrug
Novohradský, V., Prachařová, J., Kašpárková, J., Imberti, C., Bridgewater, H. E., Sadler, P. J., & Brabec, V. (2020) · Inorganic Chemistry Frontiers · doi:10.1039/d0qi00991a · Cited by 69
Vigueras, G., Marková, L., Novohradský, V., Marco, A., Cutillas, N., Kostrhunová, H., Kašpárková, J., Ruiz, J., & Brabec, V. (2021) · Inorganic Chemistry Frontiers · doi:10.1039/d1qi00856k · Cited by 67
Flieswasser, T., Loenhout, J. V., Boullosa, L. F., den Eynde, A. V., Waele, J. D., Audenaerde, J. R. M. V., Lardon, F., Smits, E., Pauwels, P., & Jacobs, J. (2020) · Cells · doi:10.3390/cells9061474 · Cited by 59
Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids
Wernitznig, D., Meier, S. M., Cseh, K., Theiner, S., Wenisch, D., Schweikert, A., Jakupec, M. A., Koellensperger, G., Wernitznig, A., Sommergruber, W., et al. (2020) · Metallomics · doi:10.1039/d0mt00227e · Cited by 53
Wang, L., Guan, R., Xie, L., Liao, X., Xiong, K., Rees, T. W., Chen, Y., Ji, L., & Chao, H. (2020) · Angewandte Chemie · doi:10.1002/ange.202013987 · Cited by 53
Konda, P., Lifshits, L. M., Roque, J. A., Cole, H. D., Cameron, C. G., McFarland, S. A., & Gujar, S. A. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1863626 · Cited by 48
Roberts, N. B., Alqazzaz, A., Hwang, J. R., Qi, X., Keegan, A. D., Kim, A. J., Winkles, J. A., & Woodworth, G. F. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2979-1 · Cited by 46
Meier, S. M., Zappe, K., Bileck, A., Kreutz, D., Tahir, A., Cichna‐Markl, M., & Gerner, C. (2018) · Metallomics · doi:10.1039/c8mt00152a · Cited by 38
Zhang, C., Liu, H., Gong, M., Yang, M., Yang, Z., Xie, Y., & Cai, L. (2021) · Materials & Design · doi:10.1016/j.matdes.2021.110087 · Cited by 28
Groer, C. E., Zhang, T., Lu, R., Cai, S., Mull, D., Huang, A., Forrest, M., Berkland, C. J., Aires, D., & Forrest, M. L. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00781 · Cited by 25
Adoke, K. U., Madukwe, J., & Faruk, M. (2020) · Regular and Young Investigator Award Abstracts · doi:10.1136/jitc-2020-sitc2020.0001 · Cited by 22
Bryce, A. H., Dronca, R. S., Costello, B. A., Infante, J. R., Ames, T. D., Jimeno, J. M., & Karp, D. D. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.6_suppl.83 · Cited by 20
Nishimura, J., Deguchi, S., Tanaka, H., Yamakoshi, Y., Yoshii, M., Tamura, T., Toyokawa, T., Lee, S., Muguruma, K., & Ohira, M. (2021) · In Vivo · doi:10.21873/invivo.12315 · Cited by 20
Novohradský, V., Marková, L., Kostrhunová, H., Kašpárková, J., Hoeschele, J. D., & Brabec, V. (2021) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2021.111628 · Cited by 19
Sakakibara, K., Sato, T., Kufe, D. W., VonHoff, D. D., & Kawabe, T. (2017) · Oncotarget · doi:10.18632/oncotarget.20968 · Cited by 17
Pan, Z., Tan, C., Rao, L., Zhang, H., Zheng, Y., Liang, H., Ji, L., & Mao, Z. (2020) · Angewandte Chemie · doi:10.1002/ange.202008624 · Cited by 8
Research works printed but not linked: 3
- Zhu, 2021, Small, 17, 1
- Rébé, 2020, Biomolecules, 10, 1
- Wernitznig, 2019, Metallomics, 11, 1044, 10.1039/c9mt00051h · DOI
Cited by
Lee, L. C.-C., & Lo, K. K.-W. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c03437 · Cited by 279
Cheng, H., Cao, X., Zhang, S., Zhang, K., Cheng, Y., Wang, J., Zhao, J., Zhou, L., Liang, X., & Yoon, J. (2023) · Advanced Materials · doi:10.1002/adma.202207546 · Cited by 260
Bioactive inorganic nanomaterials for cancer theranostics
Pei, Z., Lei, H., & Cheng, L. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00352j · Cited by 255
Immunogenic Cell Death Inducing Metal Complexes for Cancer Therapy
Zhang, L., Montesdeoca, N., Karges, J., & Xiao, H. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202300662 · Cited by 215
Metal-Based Photosensitizers as Inducers of Regulated Cell Death Mechanisms
Zhang, Y., Doan, B.-T., & Gasser, G. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00161 · Cited by 213
Metadata
- Authors
- Sen, S., Won, M., Levine, M. S., Noh, Y., Sedgwick, A. C., Kim, J. S., Sessler, J. L., & Arambula, J. F.
- Affiliations
- The University of Texas at Austin (US)
- Korea University (KR)
- Corresponding author
- Kim, Jong Seung
- Sessler, Jonathan L.
- Arambula, Jonathan F.
- ORCID
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2022
- Volume
- 51
- Issue
- 4
- Pages
- 1212-1233
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- PMC
- PMC9398513
- OpenAlex
- W4210763359
- Cited by
- 297
- References
- 75
- Citations by year
- 2026: 65 · 2025: 73 · 2024: 69 · 2023: 69 · 2022: 21
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Chemical Society Reviews (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Research Foundation of Korea (2018R1A3B1052702, 2019M3E5D1A01068998)
- National Cancer Institute (R15 CA232765)
- Welch Foundation (F-0018)
- Topics
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- immunogenic cell death, metal-based anticancer agents, platinum complexes, ruthenium complexes, iridium complexes, copper complexes, gold complexes, cancer immunotherapy, interferon-gamma, cytotoxic T lymphocytes, γδ T cells, drug delivery, combination therapy, antitumor immunity
- MeSH terms
- Immunogenic Cell Death, COVID-19, SARS-CoV-2, Antineoplastic Agents, Humans, Immunotherapy, Neoplasms, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.